Transient antibody-mucin interactions produce a dynamic molecular shield against viral invasion

Biophysical Journal

Volumn 106, Issue 9, 2014, Pages 2028-2036

  Chen, Alex ^a   McKinley, Scott A ^b   Wang, Simi ^a   Shi, Feng ^a   Mucha, Peter J ^a   Forest, M Gregory ^a,c   Lai, Samuel K ^a,c,d  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c USA and North Carolina State University   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MUCIN; NEUTRALIZING ANTIBODY; PROTEIN BINDING; VIRUS ANTIBODY;

ANTIBODY SPECIFICITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; KINETICS; METABOLISM; MUCUS; PHYSIOLOGY; UTERINE CERVIX; VAGINA; VIROLOGY;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CERVIX UTERI; FEMALE; HIV-1; HUMANS; IMMUNOGLOBULIN G; KINETICS; MUCINS; MUCUS; PROTEIN BINDING; VAGINA;

EID: 84899816777     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2014.02.038     Document Type: Article

References (55)

1. E.J. Chipperfield, and B.A. Evans Effect of local infection and oral contraception on immunoglobulin levels in cervical mucus Infect. Immun. 11 1975 215 221
2. M. Robert-Guroff IgG surfaces as an important component in mucosal protection Nat. Med. 6 2000 129 130
3. A.J. Hessell, and L. Hangartner D.R. Burton Fc receptor but not complement binding is important in antibody protection against HIV Nature 449 2007 101 104
4. R.S. Veazey, and R.J. Shattock J.P. Moore Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120 Nat. Med. 9 2003 343 346
5. J.K. Sherwood, and L. Zeitlin M. Saltzman Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital Herpes Nat. Biotechnol. 14 1996 468 471
6. C. Moog, and N. Dereuddre-Bosquet R. LeGrand Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques Mucosal Immunol 7 2014 46 56
7. A.J. Hessell, and E.G. Rakasz D.R. Burton Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers PLoS Pathog. 5 2009 e1000433
8. D.R. Burton, and J.M. Woof Human antibody effector function Adv. Immunol. 51 1992 1 84
9. R.A. Cone Mucus J. Mestecky, M.E. Lamm, W. Strober, J. Bienenstock, J.R. McGhee, Handbook of Mucosal Immunology III Ed. 2005 Academic Press London, UK 49 72
10. J.A. Hill, and D.J. Anderson Human vaginal leukocytes and the effects of vaginal fluid on lymphocyte and macrophage defense functions Am. J. Obstet. Gynecol. 166 1992 720 726
11. G.F.B. Schumacher Immunology of spermatozoa and cervical mucus Hum. Reprod. 3 1988 289 300
12. K.J. Kresge The mysteries of protection IAVI Rep. 13 2009 5
13. S. Rerks-Ngarm, and P. Pitisuttithum J.H. Kim Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand N. Engl. J. Med. 361 2009 2209 2220
14. S.S. Olmsted, and J.L. Padgett R.A. Cone Diffusion of macromolecules and virus-like particles in human cervical mucus Biophys. J. 81 2001 1930 1937
15. J.R. Clamp The relationship between secretory immunoglobulin A and mucus Biochem. Soc. Trans. 5 1977 1579 1581
16. R. Crowther, and S. Lichtman G. Forstner Failure to show secretory IgA binding by rat intestinal mucin Fed. Proc. 66 1985 691
17. W.M. Saltzman, and M.L. Radomsky R.A. Cone Antibody diffusion in human cervical mucus Biophys. J. 66 1994 508 515
18. S.K. Lai, and Y.-Y. Wang J. Hanes Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses Proc. Natl. Acad. Sci. USA 107 2010 598 603
19. Y.-Y. Wang, and A. Kannan S.K. Lai IgG in cervicovaginal mucus traps HSV and prevents vaginal Herpes infections Mucosal Immunol. 2014 2014 Feb 5. http://dx.doi.org/10.1038/mi.2013.120. [Epub ahead of print]
20. B. Pando, and S.P. Dawson J.E. Pearson Messages diffuse faster than messengers Proc. Natl. Acad. Sci. USA 103 2006 5338 5342
21. P.R. ten Wolde, and S. Tǎnase-Nicola Biophysics: pass on the message Nat. Phys. 2 2006 371 372
22. S.K. Lai, and K. Hida J. Hanes Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus J. Virol. 83 2009 11196 11200
23. S.A. Shukair, and S.A. Allen T.J. Hope Human cervicovaginal mucus contains an activity that hinders HIV-1 movement Mucosal Immunol. 6 2013 427 434
24. Reference deleted in proof.
25. P.L. Jamison, and P.H. Gebhard Penis size increase between flaccid and erect states: an analysis of the Kinsey data J. Sex Res. 24 1998 177 183
26. P.B. Pendergrass, M.W. Belovicz, and C.A. Reeves Surface area of the human vagina as measured from vinyl polysiloxane casts Gynecol. Obstet. Invest. 55 2003 110 113
27. N.E. Rehan, A.J. Sobrero, and J.W. Fertig The semen of fertile men: statistical analysis of 1300 men Fertil. Steril. 26 1975 492 502
28. P. Gupta, and J. Mellors C.R. Rinaldo High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors J. Virol. 71 1997 6271 6275
29. J. Hu, M.B. Gardner, and C.J. Miller Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells J. Virol. 74 2000 6087 6095
30. D. Maher, and X. Wu P. Southern HIV binding, penetration, and primary infection in human cervicovaginal tissue Proc. Natl. Acad. Sci. USA 102 2005 11504 11509
31. M.K. Norvell, G.I. Benrubi, and R.J. Thompson Investigation of microtrauma after sexual intercourse J. Reprod. Med. 29 1984 269 271
32. R.J. Shattock, and J.P. Moore Inhibiting sexual transmission of HIV-1 infection Nat. Rev. Microbiol. 1 2003 25 34
33. A.R. Geonnotti, and D.F. Katz Dynamics of HIV neutralization by a microbicide formulation layer: biophysical fundamentals and transport theory Biophys. J. 91 2006 2121 2130
34. B.E. Lai, and M.H. Henderson D.F. Katz Transport theory for HIV diffusion through in vivo distributions of topical microbicide gels Biophys. J. 97 2009 2379 2387
35. S.K. Lai, Y.-Y. Wang, and J. Hanes Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues Adv. Drug Deliv. Rev. 61 2009 158 171
36. J.F. Scheid, and H. Mouquet M.C. Nussenzweig Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding Science 333 2011 1633 1637
37. P. Zhu, and J. Liu K.H. Roux Distribution and three-dimensional structure of AIDS virus envelope spikes Nature 441 2006 847 852
38. C.A. Fox, S.J. Meldrum, and B.W. Watson Continuous measurement by radio-telemetry of vaginal pH during human coitus J. Reprod. Fertil. 33 1973 69 75
39. C. Tevi-Bénissan, and L. Bélec G. Grésenguet In vivo semen-associated pH neutralization of cervicovaginal secretions Clin. Diagn. Lab. Immunol. 4 1997 367 374
40. Z. Li, and S. Palaniyandi X. Zhu Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection Proc. Natl. Acad. Sci. USA 108 2011 4388 4393
41. S.J. Usala, and F.O. Usala G.F. Schumacher IgG and IgA content of vaginal fluid during the menstrual cycle J. Reprod. Med. 34 1989 292 294
42. K.M. Fahrbach, and O. Malykhina T.J. Hope Differential binding of IgG and IgA to mucus of the female reproductive tract PLoS ONE 8 2013 e76176
43. D.E. Strier, A. Chernomoretz, and S. Ponce Dawson Slow time evolution of two-time-scale reaction-diffusion systems: the physical origin of nondiffusive transport Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 65 2002 046233
44. R. Diskin, and J.F. Scheid P.J. Bjorkman Increasing the potency and breadth of an HIV antibody by using structure-based rational design Science 334 2011 1289 1293
45. K. Schønning, and O. Lund J.-E.S. Hansen Stoichiometry of monoclonal antibody neutralization of T-cell line-adapted human immunodeficiency virus type 1 J. Virol. 73 1999 8364 8370
46. X. Yang, and S. Kurteva J. Sodroski Stoichiometry of antibody neutralization of human immunodeficiency virus type 1 J. Virol. 79 2005 3500 3508
47. C. Magnus, and R.R. Regoes Estimating the stoichiometry of HIV neutralization PLOS Comput. Biol. 6 2010 e1000713
48. J.P. Hughes, and J.M. Baeten C. Celum Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples J. Infect. Dis. 205 2012 358 365
49. R. Heffron, and N. Mugo J.M. Baeten Hormonal contraceptive use and risk of HIV-1 disease progression AIDS 27 2013 261 267
50. A. Wald, and A.G. Langenberg L. Corey Effect of condoms on reducing the transmission of Herpes simplex virus type 2 from men to women JAMA 285 2001 3100 3106
51. A.A.R. Tobian, and G. Kigozi M.J. Wawer Male circumcision and Herpes simplex virus type 2 infection in female partners: a randomized trial in Rakai, Uganda J. Infect. Dis. 205 2012 486 490
52. S.I. Collins, and S. Mazloomzadeh C.B. Woodman Proximity of first intercourse to menarche and the risk of human papillomavirus infection: a longitudinal study Int. J. Cancer 114 2005 498 500
53. H. Mouquet, and J.F. Scheid M.C. Nussenzweig Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation Nature 467 2010 591 595
54. R.J. Leveque, and Z. Li The immersed interface method for elliptic equations with discontinuous coefficients and singular sources SIAM J. Numer. Anal. 31 1994 1019 1044
55. S.K. Lai, and D.E. O'Hanlon J. Hanes Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus Proc. Natl. Acad. Sci. USA 104 2007 1482 1487